7/5/2025

Janusmed fosterpåverkan

Janusmed fosterpåverkan – Okrelizumab

Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed fosterpåverkan och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Okrelizumab

Okrelizumab

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Moritz MJ et al. Transplant Pregnancy Register International. 2016 Annual Report.

  2. Deshpande NA, Coscia LA, Gomez-Lobo V, Moritz MJ, Armenti VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6:116-25.

  3. Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl. 2010;65-68.

  4. Armenti VT, Constantinescu S, Moritz MJ, Davison JM Pregnancy after transplantation. Transplantation Reviews 2008;22:223-240.

  5. EMA. Public assessment report Ocrevus. EMA [www]. [updated 2018-01-11, cited 2020-04-16].

  6. Oreja-Guevara C, Wray S, Buffels R, Zecevic D, Vukusic S. Pregnancy outcomes in patients treated with ocrelizumab. ECTRIMS Online Library. Poster. 2019

  7. Dobson R, Bove R, Borriello F, Craveiro L, Ferreira G, Hellwig K, McElrath T, Pasquarelli N, Zecevic D, Vukusic S, Oreja-Guevara C. Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis. Multiple Sclerosis Journal. 2021;27(Suppl 2):554-555.

  8. Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21(24):3365-9.

  9. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5.

  1. Moritz MJ et al. Transplant Pregnancy Register International. 2016 Annual Report.
  2. Deshpande NA, Coscia LA, Gomez-Lobo V, Moritz MJ, Armenti VT. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev Obstet Gynecol. 2013;6:116-25.
  3. Coscia LA, Constantinescu S, Moritz MJ, Frank AM, Ramirez CB, Maley WR et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl. 2010;65-68.
  4. Armenti VT, Constantinescu S, Moritz MJ, Davison JM Pregnancy after transplantation. Transplantation Reviews 2008;22:223-240.
  5. EMA. Public assessment report Ocrevus. EMA [www]. [updated 2018-01-11, cited 2020-04-16].
  6. Oreja-Guevara C, Wray S, Buffels R, Zecevic D, Vukusic S. Pregnancy outcomes in patients treated with ocrelizumab. ECTRIMS Online Library. Poster. 2019
  7. Dobson R, Bove R, Borriello F, Craveiro L, Ferreira G, Hellwig K, McElrath T, Pasquarelli N, Zecevic D, Vukusic S, Oreja-Guevara C. Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis. Multiple Sclerosis Journal. 2021;27(Suppl 2):554-555.
  8. Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21(24):3365-9.
  9. Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010;4:603-5.